Cardio-Oncology Registry
CONFUCIUS
Cardio-Oncologie: étude Pilote évaluant la faisabilité, Utilité Concrète, Interdisciplinaire d'Une Unité Spécialisée
1 other identifier
observational
5,000
1 country
1
Brief Summary
Cardio-oncology is an emerging field. Most of the data available have been issued from either retrospective analysis, industry data or pharmacovigilance data. These data sources include a number of bias. CONFUCIUS is a single tertiary centre prospective registry including all patients who have been referred for cardio-oncology assessemnt. The objectives are to provide a comprehensive vue of cardoi-oncology, enable to detect early signals of cardiotoxicity and enhance ancillary projetcts aiming at specific populations (e.g., type of cancer) and/or drugs.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2017
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2017
CompletedFirst Submitted
Initial submission to the registry
May 14, 2020
CompletedFirst Posted
Study publicly available on registry
May 29, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2027
ExpectedMay 29, 2020
May 1, 2020
5.4 years
May 14, 2020
May 25, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Incidence of cardio-toxicty
Number of patients with cardiotoxicity in a cohort of patients referred to a cardio-oncology clinic
5 years
Secondary Outcomes (10)
Analysis of cardiotoxicity
5 years
Analysis of cardioprotective strategies
5 years
Analysis of underlying cardiovacsular profile
5 years
Analysis of arrhythmias
5 years
Precision medicine
5 years
- +5 more secondary outcomes
Interventions
Non applicable
Eligibility Criteria
All prosepctive patients seen in the cardio-oncology clinic. Observational data will be collected from the medical records. Outcomes measures according to scheduled follow-up visits for their cardiovascular health.
You may qualify if:
- referred to cardio-oncology
You may not qualify if:
- refusal to participate
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Assistance Publique Hôpitaux de Paris - Centre Université de Paris
Paris, 75015, France
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 5 Years
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD, PhD, Assosiate Professor
Study Record Dates
First Submitted
May 14, 2020
First Posted
May 29, 2020
Study Start
January 1, 2017
Primary Completion
June 1, 2022
Study Completion (Estimated)
June 1, 2027
Last Updated
May 29, 2020
Record last verified: 2020-05